Variant report
Variant | esv3401398 |
---|---|
Chromosome Location | chr5:96419846-96422344 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:122)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr5:96420299-96420625 | K562 | blood: | n/a | n/a |
2 | CTCF | chr5:96421574-96421601 | Lung_OC | lung: | n/a | n/a |
3 | NFYA | chr5:96420490-96420690 | K562 | blood: | n/a | chr5:96420557-96420575 chr5:96420581-96420599 |
4 | NFYB | chr5:96420338-96420897 | K562 | blood: | n/a | n/a |
5 | NFYB | chr5:96420418-96420898 | GM12878 | blood: | n/a | n/a |
6 | SP1 | chr5:96420299-96420798 | K562 | blood: | n/a | n/a |
7 | SPI1 | chr5:96421427-96421825 | GM12878 | blood: | n/a | n/a |
8 | SPI1 | chr5:96421513-96421877 | GM12878 | blood: | n/a | n/a |
9 | SPI1 | chr5:96421560-96421747 | GM12878 | blood: | n/a | n/a |
10 | SPI1 | chr5:96421513-96421800 | GM12891 | blood: | n/a | n/a |
11 | SPI1 | chr5:96421508-96421833 | GM12891 | blood: | n/a | n/a |
12 | YY1 | chr5:96421487-96421819 | GM12878 | blood: | n/a | n/a |
13 | YY1 | chr5:96421314-96421519 | GM12878 | blood: | n/a | n/a |
14 | ZNF143 | chr5:96421333-96421396 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:96421037-96421087 | ECC-1 | luminal epithelium: | n/a |
2 | chr5:96421245-96421295 | HCF | heart: | n/a |
3 | chr5:96421245-96421295 | SK-N-MC | brain: | n/a |
4 | chr5:96421245-96421295 | HRCEpiC | kidney: | n/a |
5 | chr5:96421245-96421295 | PrEC | prostate: | n/a |
6 | chr5:96421037-96421087 | SK-N-MC | brain: | n/a |
7 | chr5:96421245-96421295 | NT2-D1 | testis: | n/a |
8 | chr5:96421245-96421295 | NB4 | blood: | n/a |
9 | chr5:96421245-96421295 | ProgFib | skin: | n/a |
10 | chr5:96421037-96421087 | HRE | kidney: | n/a |
11 | chr5:96421037-96421087 | HCT-116 | colon: | n/a |
12 | chr5:96421245-96421295 | SKMC | muscle: | n/a |
13 | chr5:96421245-96421295 | Jurkat | blood: | n/a |
14 | chr5:96421245-96421295 | AG10803 | skin: | n/a |
15 | chr5:96421245-96421295 | MCF-7 | breast: | n/a |
16 | chr5:96421037-96421087 | CMK | blood: | n/a |
17 | chr5:96421037-96421087 | AG04450 | lung: | fetal |
18 | chr5:96421245-96421295 | HAEpiC | amniotic membrane: | n/a |
19 | chr5:96421037-96421087 | BE2_C | brain: | n/a |
20 | chr5:96421245-96421295 | AG09309 | skin: | n/a |
21 | chr5:96421245-96421295 | HEEpiC | esophagus: | n/a |
22 | chr5:96421037-96421087 | MCF10A-Er-Src | breast: | n/a |
23 | chr5:96421245-96421295 | NH-A | brain: | n/a |
24 | chr5:96421245-96421295 | HIPEpiC | eye: | n/a |
25 | chr5:96421037-96421087 | HCF | heart: | n/a |
26 | chr5:96421245-96421295 | NHBE | bronchial: | n/a |
27 | chr5:96421245-96421295 | Hepatocyte | liver: | n/a |
28 | chr5:96421245-96421295 | Caco-2 | colon: | n/a |
29 | chr5:96421037-96421087 | HPAEpiC | pulmonary alveolar: | n/a |
30 | chr5:96421245-96421295 | RPTEC | kidney: | n/a |
31 | chr5:96421245-96421295 | AG04449 | skin: | fetal |
32 | chr5:96421245-96421295 | SK-N-SH_RA | brain: | n/a |
33 | chr5:96421037-96421087 | ProgFib | skin: | n/a |
34 | chr5:96421245-96421295 | T-47D | breast: | n/a |
35 | chr5:96421037-96421087 | HRPEpiC | eye: | n/a |
36 | chr5:96421037-96421087 | T-47D | breast: | n/a |
37 | chr5:96421245-96421295 | HMEC | breast: | n/a |
38 | chr5:96421245-96421295 | HEK293 | kidney: | embryo |
39 | chr5:96421245-96421295 | NHDF-neo | bronchial: | n/a |
40 | chr5:96421245-96421295 | U87 | brain: | n/a |
41 | chr5:96421037-96421087 | H1-hESC | embryonic stem cell: | embryo |
42 | chr5:96421245-96421295 | GM12891 | blood: | n/a |
43 | chr5:96421037-96421087 | PANC-1 | pancreas: | n/a |
44 | chr5:96421037-96421087 | GM12891 | blood: | n/a |
45 | chr5:96421037-96421087 | HCM | heart: | n/a |
46 | chr5:96421037-96421087 | PrEC | prostate: | n/a |
47 | chr5:96421037-96421087 | Jurkat | blood: | n/a |
48 | chr5:96421037-96421087 | HIPEpiC | eye: | n/a |
49 | chr5:96421037-96421087 | A549 | lung: | n/a |
50 | chr5:96421037-96421087 | Caco-2 | colon: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251606 | TF binding region |
ENSG00000251606 | CpG island |
ENSG00000251606 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77032099 | chr5:96419862-96419863 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs539982863 | chr5:96419865-96419866 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs376484889 | chr5:96419873-96419874 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs558071363 | chr5:96419878-96419879 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs116208374 | chr5:96419880-96419881 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs114913988 | chr5:96419882-96419883 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs377326107 | chr5:96419905-96419906 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs555873045 | chr5:96419911-96419912 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs574071583 | chr5:96419939-96419940 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs116614402 | chr5:96420023-96420024 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs147756037 | chr5:96420042-96420043 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs572256847 | chr5:96420069-96420070 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs182256655 | chr5:96420122-96420123 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs149207316 | chr5:96420135-96420136 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs543035149 | chr5:96420138-96420139 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs143342966 | chr5:96420160-96420161 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs75425473 | chr5:96420174-96420175 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs562187271 | chr5:96420181-96420182 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs35791372 | chr5:96420188-96420189 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs557491014 | chr5:96420194-96420195 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs567806272 | chr5:96420205-96420206 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs114739473 | chr5:96420229-96420230 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs148343266 | chr5:96420235-96420236 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs111844441 | chr5:96420238-96420239 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs533454733 | chr5:96420254-96420255 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs552092299 | chr5:96420255-96420256 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs569897926 | chr5:96420258-96420259 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs140784782 | chr5:96420259-96420260 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs555809770 | chr5:96420275-96420276 | Enhancers Strong transcription Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs144706610 | chr5:96420299-96420300 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs535386681 | chr5:96420311-96420312 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs10059209 | chr5:96420322-96420323 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs114668143 | chr5:96420331-96420332 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs560625946 | chr5:96420336-96420337 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs545765973 | chr5:96420353-96420354 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs138572488 | chr5:96420369-96420370 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs576278125 | chr5:96420376-96420377 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs35343902 | chr5:96420400-96420401 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs141577223 | chr5:96420407-96420408 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs562124144 | chr5:96420408-96420409 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs529373255 | chr5:96420456-96420457 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs544965443 | chr5:96420461-96420462 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs541559985 | chr5:96420467-96420468 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs186629377 | chr5:96420474-96420475 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs146179074 | chr5:96420480-96420481 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs551635152 | chr5:96420481-96420482 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs563658659 | chr5:96420482-96420483 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs530972511 | chr5:96420500-96420501 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs531530840 | chr5:96420522-96420523 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs549173022 | chr5:96420539-96420540 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:96414600-96421400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
2 | chr5:96415400-96422800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr5:96419000-96421000 | Strong transcription | Primary B cells from peripheral blood | blood |
4 | chr5:96419600-96420800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr5:96419800-96420600 | Strong transcription | Primary B cells from cord blood | blood |
6 | chr5:96420600-96421000 | Weak transcription | Primary B cells from cord blood | blood |
7 | chr5:96420800-96421400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr5:96420800-96421400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
9 | chr5:96420800-96421800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
10 | chr5:96420800-96421800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr5:96420800-96423200 | Enhancers | Primary monocytes fromperipheralblood | blood |
12 | chr5:96421000-96421200 | Weak transcription | Primary B cells from peripheral blood | blood |
13 | chr5:96421000-96421600 | Enhancers | Primary B cells from cord blood | blood |
14 | chr5:96421200-96421400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
15 | chr5:96421200-96422200 | Enhancers | Primary B cells from peripheral blood | blood |
16 | chr5:96421400-96421800 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
17 | chr5:96421400-96421800 | Enhancers | GM12878-XiMat | blood |
18 | chr5:96421400-96423000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
19 | chr5:96421600-96421800 | Flanking Active TSS | Primary B cells from cord blood | blood |
20 | chr5:96421800-96422400 | Enhancers | Primary B cells from cord blood | blood |
21 | chr5:96421800-96424800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
22 | chr5:96421800-96425000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
23 | chr5:96422200-96422400 | Enhancers | GM12878-XiMat | blood |
24 | chr5:96422200-96422600 | Weak transcription | Primary B cells from peripheral blood | blood |